Dialysis providers oppose longer coverage of kidney transplant drugs

12/15/2009 | NYTimes.com

The National Kidney Foundation joined drugmakers and dialysis providers in opposing a measure in Congress that would extend Medicare coverage beyond 36 months for immunosuppressant drugs given to patients after a kidney transplant because they say it would be paid for by reducing reimbursements to dialysis patients. Kidney Care Partners, a coalition of dialysis providers, drugmakers and others, said although the bundled-payment method would help one group of patients, it "would potentially put another very vulnerable group of patients at risk."

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN